Ivermectin B1 Mono-sugar Derivative
| Product Name | Ivermectin B1 Mono-sugar Derivative |
|---|---|
| Alternate Names | Ivermectin Impurities, Impurities of Ivermectin |
| CAT No. | CS-T-56937 |
| CAS No. | 71837-27-9 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 730.92 g/mol |
| Mol. For. | C₄₁H₆₂O₁₁ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Ivermectin |
| Purity | 95% |
| Canonical Smiles | CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)O)OC)C)C |
| InchIKey | IDRWWNAYSYRQBV-DQDVCMNESA-N |
| Inchl | InChI=1S/C41H62O11/c1-9-22(2)37-25(5)15-16-40(52-37)20-30-18-29(51-40)14-13-24(4)36(50-33-19-32(46-8)35(43)27(7)48-33)23(3)11-10-12-28-21-47-38-34(42)26(6)17-31(39(44)49-30)41(28,38)45/h10-13,17,22-23,25,27,29-38,42-43,45H,9,14-16,18-21H2,1-8H3/b11-10-,24-13-,28-12?/t22-,23-,25-,27-,29+,30-,31-,32-,33-,34+,35-,36-,37+,38+,40+,41+/m0/s1 |
| IUPAC | (1R,4S,5'S,6R,6'R,8R,10Z,12S,13S,14Z,20R,21R,24S)-6'-[(2S)-butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Ivermectin B1 Mono-sugar Derivative is a chemical compound that is widely used as an anti-parasitic agent in both human and veterinary medicine. It is a derivative of the well-known drug Ivermectin, which is commonly used to treat various parasitic infections in animals and humans, including scabies and river blindness.
Ivermectin B1 Mono-sugar Derivative is a semi-synthetic compound that is produced by chemically modifying the parent compound, Ivermectin. The modification involves the addition of a sugar molecule to the parent compound, which enhances its pharmacological properties, including its solubility in water.
The chemical structure of Ivermectin B1 Mono-sugar Derivative is complex, containing multiple rings and functional groups. It is a macrocyclic lactone compound that acts by binding to specific receptors in the nervous system of parasites, leading to their paralysis and death.
Ivermectin B1 Mono-sugar Derivative is mainly used in the treatment of parasitic infections such as onchocerciasis (river blindness), strongyloidiasis (intestinal infection), and scabies. It is also used in veterinary medicine to treat various parasitic infections in animals.
The safety and efficacy of Ivermectin B1 Mono-sugar Derivative have been extensively studied, and it is generally considered a safe and effective drug for the treatment of parasitic infections. However, like all drugs, it may cause side effects, including gastrointestinal disturbances, headache, and dizziness. It is important to use this drug only under the guidance of a healthcare professional.
Get an Instant Quote
Related Compounds
Ivermectin EP Impurity C | Ivermectin Photolytic degradation impurity-2 (aldehyde impurity) | Ivermectin aglycone | Ivermectin EP Impurity J | Desmethyl IVERMECTIN B1A | Ivermectin Impurity 1 | Ivermectin EP Impurity E | Ivermectin EP Impurity F | Ivermectin(Secondary Standards traceble to USP) | Ivermectin 8a-oxo-H2B1a | Ivermectin B1 Aglycon | rac-2,3-Dehydro-3,4-dihydro Ivermectin |